Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1949 2
1950 2
1951 2
1952 1
1953 1
1954 3
1955 5
1956 6
1957 9
1958 10
1959 11
1960 13
1961 11
1962 12
1963 18
1964 22
1965 17
1966 17
1967 16
1968 21
1969 18
1970 27
1971 12
1972 16
1973 23
1974 19
1975 27
1976 27
1977 36
1978 25
1979 49
1980 40
1981 33
1982 52
1983 44
1984 44
1985 64
1986 63
1987 52
1988 64
1989 74
1990 43
1991 61
1992 65
1993 55
1994 85
1995 74
1996 89
1997 81
1998 72
1999 78
2000 74
2001 74
2002 71
2003 66
2004 96
2005 99
2006 107
2007 114
2008 133
2009 136
2010 135
2011 166
2012 218
2013 221
2014 244
2015 227
2016 225
2017 226
2018 283
2019 310
2020 295
2021 705
2022 938
2023 665
2024 219

Text availability

Article attribute

Article type

Publication date

Search Results

7,105 results

Results by year

Filters applied: . Clear all
Page 1
Epidemiology and clinical manifestations of mucormycosis.
Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Petrikkos G, et al. Clin Infect Dis. 2012 Feb;54 Suppl 1:S23-34. doi: 10.1093/cid/cir866. Clin Infect Dis. 2012. PMID: 22247442 Review.
Mucormycosis also remains a threat in patients with diabetes mellitus in the Western world. ...This review describes the emerging epidemiology and the clinical manifestations of mucormycosis....
Mucormycosis also remains a threat in patients with diabetes mellitus in the Western world. ...This review describes the emerging epi …
Mucormycosis in COVID-19 patients.
Sundaram N, Bhende T, Yashwant R, Jadhav S, Jain A. Sundaram N, et al. Indian J Ophthalmol. 2021 Dec;69(12):3728-3733. doi: 10.4103/ijo.IJO_1316_21. Indian J Ophthalmol. 2021. PMID: 34827032 Free PMC article. Review.
Mucormycosis, commonly known as 'Black Fungus' which was then a rare fungal infection, has suddenly come to light post the COVID-19- pandemic, more so during the second wave in India. ...The present review will focus on the pathophysiology, etiology, outcomes of some case …
Mucormycosis, commonly known as 'Black Fungus' which was then a rare fungal infection, has suddenly come to light post the COVID-19- …
Mucormycosis medications: a patent review.
Imran M, A S A, Tauseef M, Khan SA, Hudu SA, Abida. Imran M, et al. Expert Opin Ther Pat. 2021 Nov;31(11):1059-1074. doi: 10.1080/13543776.2021.1939308. Epub 2021 Jun 18. Expert Opin Ther Pat. 2021. PMID: 34082658 Review.
Accordingly, it is essential to provide more treatment options for mucormycosis. AREA COVERED: This patent review focuses on the granted patents and patent applications related to medication for mucormycosis treatment from the publication year of the amphotericin-B …
Accordingly, it is essential to provide more treatment options for mucormycosis. AREA COVERED: This patent review focuses on the gran …
COVID-19-associated mucormycosis in India: Why such an outbreak?
Pasquier G. Pasquier G. J Mycol Med. 2023 Aug;33(3):101393. doi: 10.1016/j.mycmed.2023.101393. Epub 2023 May 9. J Mycol Med. 2023. PMID: 37182234 Free PMC article. Review.
An unprecedented mucormycosis outbreak occurred in India during the second COVID-19 wave in spring 2021. COVID-19-associated mucormycosis (CAM) was observed, mainly rhino-orbito-cerebral mucormycosis (ROCM), in patients with poorly controlled diabetes and tre …
An unprecedented mucormycosis outbreak occurred in India during the second COVID-19 wave in spring 2021. COVID-19-associated mucor …
Epidemiology of Mucormycosis in India.
Prakash H, Chakrabarti A. Prakash H, et al. Microorganisms. 2021 Mar 4;9(3):523. doi: 10.3390/microorganisms9030523. Microorganisms. 2021. PMID: 33806386 Free PMC article. Review.
Mucormycosis is an angioinvasive disease caused by saprophytic fungi of the order Mucorales. ...Patients with postpulmonary tuberculosis and chronic kidney disease are at additional risk of developing mucormycosis in this country. Trauma is a risk factor for cutaneo …
Mucormycosis is an angioinvasive disease caused by saprophytic fungi of the order Mucorales. ...Patients with postpulmonary tuberculo …
Mucormycosis.
Sugar AM. Sugar AM. Clin Infect Dis. 1992 Mar;14 Suppl 1:S126-9. doi: 10.1093/clinids/14.supplement_1.s126. Clin Infect Dis. 1992. PMID: 1562684 Review.
Mucormycosis refers to the disease caused by a growing number of members of the Mucorales. ...The role of new azole derivatives in the treatment of mucormycosis is unknown....
Mucormycosis refers to the disease caused by a growing number of members of the Mucorales. ...The role of new azole derivatives in th …
Cutaneous mucormycosis.
Skiada A, Petrikkos G. Skiada A, et al. Skinmed. 2013 May-Jun;11(3):155-9; quiz 159-60. Skinmed. 2013. PMID: 23930354 Review.
Mucormycosis is an invasive fungal infection caused by fungi of the order Mucorales, mainly affecting immunocompromised patients. Cutaneous mucormycosis is the third most common clinical form of the disease, after pulmonary and rhino-cerebral. ...
Mucormycosis is an invasive fungal infection caused by fungi of the order Mucorales, mainly affecting immunocompromised patients. Cut …
Cutaneous mucormycosis.
Castrejón-Pérez AD, Welsh EC, Miranda I, Ocampo-Candiani J, Welsh O. Castrejón-Pérez AD, et al. An Bras Dermatol. 2017 May-Jun;92(3):304-311. doi: 10.1590/abd1806-4841.20176614. An Bras Dermatol. 2017. PMID: 29186239 Free PMC article. Review.
Cutaneous mucormycosis is an emerging fungal infection caused by opportunistic fungi of the phylum Glomeromycota. ...
Cutaneous mucormycosis is an emerging fungal infection caused by opportunistic fungi of the phylum Glomeromycota. ...
Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis.
Lynch JP 3rd, Fishbein MC, Abtin F, Zhanel GG. Lynch JP 3rd, et al. Expert Rev Anti Infect Ther. 2023 Jul-Dec;21(7):723-736. doi: 10.1080/14787210.2023.2220964. Epub 2023 Jun 7. Expert Rev Anti Infect Ther. 2023. PMID: 37262298 Review.
AREAS COVERED: The authors discuss the prevalence, risk factors, and clinical features of mucormycosis. A literature search of mucormycosis was performed via PubMed (up to November 2022), using the key words: invasivefungal infections; mold; mucormycosis;Muco …
AREAS COVERED: The authors discuss the prevalence, risk factors, and clinical features of mucormycosis. A literature search of muc …
Mucormycosis--from the pathogens to the disease.
Binder U, Maurer E, Lass-Flörl C. Binder U, et al. Clin Microbiol Infect. 2014 Jun;20 Suppl 6:60-6. doi: 10.1111/1469-0691.12566. Epub 2014 Feb 24. Clin Microbiol Infect. 2014. PMID: 24476149 Free article. Review.
Mucormycosis is an emerging fungal infection worldwide, with devastating disease symptoms and diverse clinical manifestations. ...The aetiological agents involved in the disease have been re-classified due to changes in taxonomy and nomenclature, which also led to appropri …
Mucormycosis is an emerging fungal infection worldwide, with devastating disease symptoms and diverse clinical manifestations. ...The …
7,105 results